Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Textbook of Endocrine Surgery
Orlo H Clark, Quan-Yang Duh, Electron Kebebew, Jessica E Gosnell, Wen T Shen
SECTION 1: THYROID
CHAPTER 1:
Thyroid Physiology
THYROID EMBRYOGENESIS
THYROID HORMONE PHYSIOLOGY
Iodide Metabolism and Uptake
Synthesis of Thyroid Hormone
Peripheral Transport and Metabolism of Thyroid Hormones
Peripheral Action of Thyroid Hormones
Thyroid Hormone Regulation
Autoregulatory Mechanisms
CALCITONIN PHYSIOLOGY
Calcitonin Secretion
Peripheral Action of Calcitonin
SUMMARY
CHAPTER 2:
Surgical Anatomy and Embryology of the Thyroid and Parathyroid Glands and Recurrent and External Laryngeal Nerves
THYROID EMBRYOLOGY AND DEVELOPMENTAL ABNORMALITIES
PARATHYROID EMBRYOLOGY AND DEVELOPMENTAL ABNORMALITIES
SURGICAL ANATOMY OF THE THYROID AND PARATHYROID GLANDS
CHAPTER 3:
Endemic Iodine Deficiency and Goiters: Epidemiology, Pathophysiology and Management
INTRODUCTION
EPIDEMIOLOGY OF IODINE DEFICIENCY AND ENDEMIC GOITERS
Methods of Assessment of Iodine Deficiency and Endemic Goiters
Current Status of Global Iodine Nutrition
ETIOLOGY OF IODINE DEFICIENCY AND ENDEMIC GOITERS
PATHOPHYSIOLOGY OF ENDEMIC GOITER
MORPHOLOGIC CHANGES IN ENDEMIC GOITER
ASSESSMENT AND DIAGNOSIS OF ENDEMIC GOITERS
PROPHYLAXIS AND CONTROL OF IODINE DEFICIENCY AND ENDEMIC GOITERS
GLOBAL IODIZATION PROGRAMS AND THEIR EFFECT ON IODINE DEFICIENCY AND ENDEMIC GOITERS PREVENTION AND CONTROL
MEDICAL TREATMENT OF ENDEMIC GOITERS
Iodine Supplementation
Levothyroxine
RAI Treatment
Surgical Treatment of Endemic Goiters
Indications for Surgical Treatment
SUMMARY
CHAPTER 4:
Thyroglossal Duct Cysts and Sublingual Thyroid
INTRODUCTION
EMBRYOLOGY AND ANATOMY
PATHOLOGY
CLINICAL PRESENTATION AND DIFFERENTIAL DIAGNOSIS
INVESTIGATIONS
MANAGEMENT
CHAPTER 5:
Sporadic Nontoxic Goiter
CAUSES OF GOITER
Genetic Factors
Environmentally Induced Goiter
Iodine Deficiency
Environmental and other Factors
PATHOGENESIS
Goiter Growth
Nodule Formation
Autonomy
NATURAL HISTORY
INTERVENTION VERSUS OBSERVATION
CLINICAL EVALUATION
History
Physical Examination
Laboratory Evaluation
Imaging
Biopsy
Observation
TREATMENT
Extent of Surgery
SUMMARY
CHAPTER 6:
Thyroiditis
INTRODUCTION
ACUTE (SUPPURATIVE) THYROIDITIS
Etiology and Pathogenesis
Histologic Features
Clinical Presentation
Differential Diagnosis
Diagnostic Tests
Treatment
SUBACUTE THYROIDITIS
Painful (de Quervain's) Thyroiditis
Etiology and Pathogenesis
Histologic Features
Clinical Presentation
Differential Diagnosis
Diagnostic Studies
Treatment
Clinical Course
Painless Thyroiditis
Etiology and Pathogenesis
Histologic Features
Clinical Presentation
Diagnostic Tests
Differential Diagnosis
Treatment
Clinical Course
CHRONIC THYROIDITIS
Lymphocytic (Hashimoto's) Thyroiditis
Etiology and Pathogenesis
Environmental Factors
Genetic Predisposition
Histologic Features
Clinical Presentation
Diagnostic Studies
Differential Diagnosis
Clinical Course
Treatment
Riedel's Thyroiditis
Etiology and Pathogenesis
Histologic Features
Clinical Features
Differential Diagnosis
Diagnostic Studies
Treatment
SUMMARY
CHAPTER 7:
Hypothyroidism: Pearls for the Endocrine Surgeon
PREVALENCE OF PRIMARY HYPOTHYROIDISM
CAUSES OF PRIMARY HYPOTHYROIDISM
DIAGNOSIS OF PRIMARY HYPOTHYROIDISM
Subclinical Hypothyroidism
THYROID HORMONE SUPPLEMENTATION/REPLACEMENT
THYROID REPLACEMENT DOSING AFTER TOTAL THYROIDECTOMY FOR BENIGN DISEASE
HYPOTHYROIDISM AFTER HEMITHYROIDECTOMY
SUMMARY
CHAPTER 8:
Graves’ and Plummer's Diseases: Medical and Surgical Management
INTRODUCTION
ROBERT JAMES GRAVES (1796–1853)
HENRY STANLEY PLUMMER (1874–1937)
SIR THOMAS PEEL DUNHILL (1876–1957)
GRAVES’ DISEASE
Epidemiology
Clinical Manifestations
Pathogenesis
Diagnosis
Therapy
Medical Management
Radioactive Iodine
Surgical Intervention
PLUMMER'S DISEASE
Pathogenesis
Clinical Manifestations
Diagnosis
Therapy
CONCLUSION
CHAPTER 9:
Thyroid-Stimulating Hormone and TSH Suppressive Therapy in Patients after Thyroid Operations for Nodular Goiter or Differentiated Thyroid Cancer
HISTORY OF TSH AND TSH SUPPRESSIVE THERAPY
PREOPERATIVE SERUM TSH LEVELS IN PATIENTS WITH BENIGN MULTINODULAR GOITER AND PATIENTS WITH DIFFERENTIATED THYROID CANCER
TSH AND THYROCYTE GROWTH – BIOCHEMICAL AND EXPERIMENTAL RESULTS
ACTIVATED TSH-RECEPTOR, SECOND MESSENGER SYSTEMS, AND THYROCYTE GROWTH
TSH EFFECT ON CELLULAR GROWTH IN PRIMARY THYROCYTES IN CULTURE
TSH EFFECT ON PERMANENT HUMAN CELL CULTURES IN VITRO
EFFECT OF CONSTITUTIVELY ACTIVATED TSH-R IN TRANSGENIC MICE
CLINICAL DATA OF MODERATE AND STRINGENT TSH-SUPPRESSIVE THERAPY: BENEFITS AND ADVERSE EFFECTS
Serum TSH and Goiter Recurrence in Benign Multinodular Goiter Resected with Less than Total Thyroidectomy
Serum TSH Suppression for Preventing Thyroid Cancer Recurrence (Moderate Versus Stringent TSH Suppression)
Possible Long-Term Complications of Serum TSH Suppression and Iatrogenic Hyperthyroidism
CONCLUSION
CHAPTER 10:
Approach to Thyroid Nodules
EPIDEMIOLOGY
PATIENT HISTORY
PHYSICAL EXAMINATION
LARYNGOSCOPY
DIAGNOSTIC EVALUATION
Biochemical Tests
Imaging
Ultrasound
Radionuclide Scanning
Fine-Needle Aspiration
THE BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY
MANAGEMENT
Follow-up
Medical Management
Surgical Management
CHAPTER 11:
Pediatric Thyroid Carcinoma
INTRODUCTION
RISK FACTORS
Radiation Exposure
Genetics
CLINICAL PRESENTATION
DIAGNOSTIC WORKUP
TREATMENT
Surgical Management of DTC
Radioactive Iodine
Thyroid-Stimulating Hormone Suppression
Treatment of MTC
FOLLOW-UP AND PROGNOSIS
SUMMARY
CHAPTER 12:
Rationale for Hemithyroidectomy
INTRODUCTION
PROGNOSTIC FACTORS IN THYROID CANCER
Risk Group Stratification
Biology of Thyroid Cancer
Total versus Less than Total Thyroidectomy—The Debate Continues
REASONS FOR INCREASING INCIDENCE OF TOTAL THYROIDECTOMY
DEFINITE INDICATIONS FOR TOTAL THYROIDECTOMY
FOLLICULAR AND HÜRTHLE CELL CARCINOMA AND THE ROLE OF LOBECTOMY
COMPLETION THYROIDECTOMY
CONCLUSION
CHAPTER 13:
Papillary Thyroid Carcinoma: Rationale for Total Thyroidectomy
SUMMARY
CHAPTER 14:
Nonsurgical Treatment of PTC
OBSERVATION OF PAPILLARY MICROCARCINOMA
Classification of PMC
Frequent Lymph Node Metastasis and Multicentricity of PMC on Pathological Examination
Prognostic Factors of PMC
Age
Extrathyroid Extension
Clinical Lymph Node Metastasis (N Factor)
Pathological Lymph Node Metastasis (pN)
Distant Metastasis at Diagnosis (M Factor)
Other Prognostic Factors
Observation for Low-Risk PMC
Selection of PMC Patients Suitable for Observation
How to Observe Low-Risk PMC by Ultrasonography
Limitations of Ultrasonography for PMC Evaluation
Outcomes of Observation of Low-Risk PMC
Indications for Surgery for PMC after Observation
Extent of Surgery and Postoperative Follow-up for PMC after Observation
Outcomes of PMC Patients Who Underwent Surgery after Observation
THERAPEUTIC STRATEGIES OTHER THAN OBSERVATION AND SURGERY FOR LOW-RISK PMC
SUMMARY
CHAPTER 15:
Follicular Neoplasms of the Thyroid
INTRODUCTION
Incidence and Prevalence of Follicular Neoplasms
Presentation and Identification of Follicular Neoplasms
FOLLICULAR ADENOMA
Pathologic Features of Follicular Adenoma
Clinical Features of Follicular Adenoma
FOLLICULAR CARCINOMA
Pathologic Features of Follicular Carcinoma
Clinical Features of Follicular Carcinoma
Prognosis of Follicular Carcinoma
Treatment of Follicular Carcinoma: Surgery
Treatment of Follicular Carcinoma: Adjuvant Therapy
CHAPTER 16:
Hürthle Cell Adenoma and Carcinoma
INTRODUCTION
HISTORICAL BACKGROUND
ORIGIN AND CLASSIFICATION
CLINICAL CHARACTERISTICS
Histology
Demographics
Risk Factors
Presentation
DIAGNOSIS
Histopathology
Fine-Needle Aspiration
Molecular Analysis
Frozen Section Evaluation
MANAGEMENT
Surgical Procedure
Radioactive Iodine and Other Modalities
Postoperative Follow-Up
PROGNOSIS
SUMMARY
CHAPTER 17:
Medullary Thyroid Cancer
INTRODUCTION
HEREDITARY MEDULLARY THYROID CANCER
INITIAL SURGICAL TREATMENT OF CLINICALLY EVIDENT DISEASE
MANAGEMENT OF REGIONAL LYMPH NODES IN CLINICALLY EVIDENT DISEASE
MANAGEMENT OF LYMPH NODES DURING PREVENTATIVE SURGERY FOR HEREDITARY MTC
MANAGEMENT OF RECURRENT OR PERSISTENT DISEASE
CONCLUSION
CHAPTER 18:
Surgical Ultrasonography of the Thyroid and Parathyroid Glands
PREAMBLE AND HISTORY
BASIC PHYSICS
HARDWARE AND SETUP
THE EXAMINATION
PRINCIPAL FEATURES IN THYROID SONOGRAPHY
SPECIFIC FEATURES IN THYROID SONOGRAPHY
Normal Thyroid
BENIGN THYROID DISORDERS
MALIGNANT THYROID DISORDERS
CONTROVERSY AND REALITY
PRINCIPAL FEATURES IN PARATHYROID SONOGRAPHY
SAFETY
CHAPTER 19:
Thyroid Cytology: Benefits and Problems
INTRODUCTION
NONDIAGNOSTIC/UNSATISFACTORY
BENIGN THYROID NODULE
Benign Follicular Nodule
Chronic Lymphocytic (Hashimoto's) Thyroiditis
Acute Thyroiditis
Subacute (Granulomatous) Thyroiditis
ATYPIA OF UNDETERMINED SIGNIFICANCE OR FOLLICULAR LESION OF UNDETERMINED SIGNIFICANCE
FOLLICULAR NEOPLASM/SUSPICIOUS FOR FOLLICULAR NEOPLASM
SUSPICIOUS FOR MALIGNANCY AND MALIGNANT
Papillary Thyroid Carcinoma
Cytomorphological Features of Papillary Thyroid Carcinoma
False-Positive Diagnosis
False-Negative Diagnosis
Error in Classification of Tumor Type
Medullary Carcinoma
Poorly Differentiated Carcinoma
Anaplastic Carcinoma
Primary Thyroid Lymphoma
Metastatic Carcinoma
CHAPTER 20:
Localization Tests in Patients with Thyroid Cancer
DIFFERENTIATED THYROID CANCER OF FOLLICULAR CELL ORIGIN
Ultrasonography for Papillary Cancer
Radioiodine Scintigraphy
Scintigraphy with Alternative Nucleotides
Thallium 201 Chloride
Technetium 99m Sestamibi
Invasion of Papillary Cancer to Adjacent Organs
Imaging of Metastases of Differentiated Thyroid Cancer with Positron Emission Tomography
Fluorine-18 Fluorodeoxyglucose
Iodine 124
Follow-Up of Patients Who Lost Differentiation Markers
IMAGE DIAGNOSIS OF MEDULLARY CANCER
Ultrasonography for Medullary Thyroid Cancer
Radioiodinated Metaiodobenzylguanidine
Imagining in the Follow-Up of Postoperative Medullary Thyroid Cancer
CONCLUSION
CHAPTER 21:
Papillary and Follicular Carcinoma: Surgical and Radioiodine Treatment of Distant Metastases
INTRODUCTION
LOCATION OF DISTANT METASTASES
DIAGNOSTIC PROCEDURES
Serum Thyroglobulin
Iodine-131 Whole Body Scan and SPECT CT
Positron Emission Tomography/ Computed Tomography (PET/CT) Scan
THERAPEUTIC PROCEDURES
Surgery and Adjunct Interventions
Radioactive Iodine Treatment
Side Effects and Complications of Radioactive Iodine Therapy
Prognostic Factors
SUMMARY
CHAPTER 22:
Risk Stratification Systems for Papillary Thyroid Carcinoma
INTRODUCTION
COMPARISON OF CLASSIFICATION SYSTEMS
European Organization for Research and Treatment of Cancer
AJCC/UICC TNM
AGES
AMES
MACIS
Other Classification Systems
Comparing Classification Systems
REDEFINING PTC MANAGEMENT USING A RISK ADAPTED PARADIGM
Initial Risk Stratification
Preoperative Stage
Operative Decision Making
Postoperative Stage
Secondary Risk Stratification
Surveillance and Restaging
CHAPTER 23:
Anaplastic Carcinoma of the Thyroid Gland
INTRODUCTION
EPIDEMIOLOGY
STAGING
CLINICAL PRESENTATION
PATHOLOGY AND MOLECULAR ALTERATIONS
DIAGNOSIS
GOALS OF CARE
TREATMENT
SURGERY
AIRWAY MANAGEMENT
ENTERAL ACCESS
EXTERNAL BEAM RADIOTHERAPY
CYTOTOXIC CHEMOTHERAPY AND TARGETED THERAPEUTICS
POSTOPERATIVE EVALUATION
CONCLUSION
CHAPTER 24:
Unusual Thyroid Cancers, Lymphoma, and Metastases to the Thyroid
AGGRESSIVE VARIANTS OF WELL- DIFFERENTIATED THYROID CARCINOMA
Introduction
Solid Variant of PTC
Clinical Features
Pathology
Diagnosis and Treatment
Diffuse Sclerosing Variant of PTC
Clinical Features
Pathology
Diagnosis and Treatment
Tall Cell Variant of PTC
Clinical Features
Pathology
Diagnosis and Treatment
Columnar Cell Carcinoma
Clinical Features
Pathology
Diagnosis and Treatment
POORLY DIFFERENTIATED THYROID CARCINOMA
Clinical Features
Pathology
Diagnosis and Treatment
Hyalinizing Trabecular Tumor or Paraganglioma-Like Adenoma of the Thyroid
Mucoepidermoid Carcinoma/Sclerosing Mucoepidermoid Carcinoma with Eosinophilia
Clinical Features
Pathology
Diagnosis and Treatment
SQUAMOUS CELL CARCINOMA
PLASMACYTOMA
Clinical Features
Pathology
Diagnosis and Treatment
PARAGANGLIOMA
Clinical Features
Pathology
Diagnosis and Treatment
CLINICAL FEATURES
PATHOLOGY
DIAGNOSIS AND TREATMENT
SARCOMA
TERATOMA
DIAGNOSIS AND TREATMENT
SUMMARY
CHAPTER 25:
Recurrent Differentiated Thyroid Cancer
INTRODUCTION
RISK GROUPS STRATIFICATION FOR RECURRENT DTC
Factors Related to the Patient
Factors Related to the Tumor
Factors Related to Treatment
DEFINITION AND CLASSIFICATION OF RECURRENT DTC
THYROID BED RECURRENCE
PREVENTION OF RECURRENT DISEASE
Preoperative Recognition of Malignancy
Surgical Intervention
TSH Suppression Therapy
The Use of Adjuvant I-131 (RAI Ablation)
External Radiotherapy
DIAGNOSIS OF RECURRENT
RAI Scintigraphy
Measurement of Serum Thyroglobulin Levels
Ultrasonography of the Neck
Computerized Tomography and Magnetic Resonance Imaging
Positron Emission Tomography
Imaging Algorithm for the Follow-up of Thyroid Cancers
TREATMENT OF RECURRENT AND METASTATIC CANCER
SUMMARY
CHAPTER 26:
Nerve Monitoring During Thyroidectomy
HISTORY
ANATOMY
Superior Laryngeal Nerve
Recurrent Laryngeal Nerve
Recurrent Laryngeal-SLN Anastomoses
REPORTED INCIDENCE OF INJURY
INTRAOPERATIVE NERVE MONITORING
Options
Effectiveness
Benefits
TROUBLESHOOTING
MEDICOLEGAL ISSUES
ETHICAL ISSUES
CONCLUSION
CHAPTER 27:
Evaluation of Voice and Larynx at Thyroid and Parathyroid Operations
INTRODUCTION
THE ANATOMY OF VOICE
INCIDENCE OF RLN PARALYSIS
CAUSES OF THYROIDECTOMY- RELATED DYSHPHONIA: NEURAL AND NONNEURAL CAUSES
PREOPERATIVE LARYNGEAL EXAMINATION
LARYNGEAL EXAMINATION GUIDELINES
AAO-HNS Clinical Practice Guideline Review: Improving Voice Outcomes after Thyroid Surgery
Statement 1: All Patients Undergoing Thyroidectomy should have a Preoperative Baseline Voice Assessment
Statement 2a: Preoperative Laryngeal Examination is Recommended for all Patients with Impaired Voice
Statement 2b: Preoperative Laryngeal Assessment in Patients with Normal Voice
Statement 3: Patient Education on Voice Outcomes
Statement 4: Communication with Anesthesiologist
Statement 5: Identifying RLN during Surgery
Statement 6: Protection of Superior Laryngeal Nerve
Statement 7: Intraoperative EMG Monitoring
Statement 8: Intraoperative Corticosteroids
Statement 9: Postoperative Voice Assessment
Statement 10: Postoperative Laryngeal Examination in Patients with Abnormal Voice
Statement 11: Voice Rehabilitation
INTRAOPERATIVE NEURAL ELECTROPHYSIOLOGICAL MONITORING
POSTOPERATIVE LARYNGEAL EXAMINATION
FLEXIBLE LARYNGOSCOPY
SUMMARY
CHAPTER 28:
Thyroidectomy—Standard
INTRODUCTION/HISTORICAL PERSPECTIVE
INDICATIONS FOR THYROIDECTOMY
PREOPERATIVE PREPARATION
ANESTHETIC CONSIDERATIONS
PATIENT POSITIONING/PREPARATION
OPERATIVE APPROACH
General Principles
Incision Placement
Flap Elevation and Dissection of Strap Muscles
Upper Pole Dissection
Middle and Lower Poles
Substernal Goiters
Finishing Touches
THYROIDECTOMY RESULTS
Recurrent Laryngeal Nerve Injury
Hypoparathyroidism
Bleeding
Infection
Scar Formation
CONCLUSIONS
CHAPTER 29:
Thyroidectomy—Minimally Invasive Video-Assisted Thyroidectomy (MIVAT)
BACKGROUND
INDICATIONS FOR MIVAT
THE TECHNIQUE
Anesthesia
Positioning
Instruments
Procedure
Step 1: Incision and Access to the Thyroid Region
Step 2: Section of the Upper Pedicle
Step 3: Identification of the Recurrent Nerve and of the Parathyroid Glands
Step 4: Mobilization and Extraction of the Thyroid Lobe and Completion of the Lobectomy
Step 5: Examination and Reapproximation of the Tissues
OUTCOMES AND CONCLUSIONS
CHAPTER 30:
Thyroid Surgery—Robotic
INTRODUCTION
TRAINING SURGEONS TO PERFORM ROBOTIC THYROID SURGERY
PREOPERATIVE PATIENT'S WORKUP FOR ROBOTIC THYROID SURGERY
OPERATIVE PROCEDURE
Robotic Thyroidectomy Procedure
Patient Preparation and Creation of a Working Space
Robot Positioning and Docking
Console Stage
Robotic Radical Neck Dissection Procedure
EVIDENCE
Oncologic Outcomes after Robotic Thyroidectomy and Radical Neck Dissection
Operative Safety after Robotic Thyroidectomy and Radical Neck Dissection
Quality of Life Including Functional Outcomes after Robotic Thyroidectomy and Radical Neck Dissection
Cosmetic Outcomes after Robotic Thyroid Surgery
Voice and Swallowing Discomfort after Robotic Thyroid Surgery
Comparative Analysis of other QoL Measures, Including Pain, Discomfort, and Motor and Sensory Changes, after Robotic and Conventional Open Thyroidectomy
Comparative Analysis of Recovery of Motor Functions Across MRND Modalities
Surgeon's Perspectives on Robotic Thyroid Surgery
Operative Time and Surgical Learning Curve after Robotic Thyroid Surgery
Surgeon's Ergonomic Considerations for Robotic Thyroidectomy
Impact of the Surgical Approach to Robotic Thyroidectomy and Radical Neck Dissection on Outcome
CONCLUSION
CHAPTER 31:
Nontraditional Approaches and Remote Access to Thyroidectomy
INTRODUCTION
“NONTRADITIONAL” APPROACH DEFINED
Technological Advancements
Benefit, Indications, and Contraindications
Drawbacks of Remote Access
“Below the Neck” Approaches
Infraclavicular
Axillary
Breast and Breast-Axillary Hybrids
“Above the Neck” Approaches
Transoral
Retroauricular/“Facelift” and Related Hybrids
CONCLUSION
CHAPTER 32:
Alcohol and Radiofrequency Ablation of Thyroid Cancer Recurrence and Metastasis
INTRODUCTION
INDICATIONS FOR ABLATION
Alcohol Ablation Biochemistry
Alcohol Ablation Technique and Risks
Radiofrequency Ablation Biophysics
Radiofrequency Ablation Technique and Risks
CHOOSING A TECHNIQUE
CONTROVERSIES AND THE FUTURE
SUMMARY
CHAPTER 33:
New Technology in Thyroid and Parathyroid Surgery
INTRODUCTION
NEW TECHNOLOGY FOR EXTRACERVICAL TRANSAXILLARY THYROIDECTOMY: CONCEPT, PRESENTATION, AND PRECLINICAL WORK AT THE IRCAD
Acute Swine Study
Surgical Procedure (Figs. 33.2A to F)
Cadaver Study (Figs. 33.3A to G)
Results
Porcine Study
Cadaver Study
Lessons Learned and Points to Improve
PREOPERATIVE PLANNING AND INTRAOPERATIVE NAVIGATION IN THYROID SURGERY
CONCLUSION
CHAPTER 34:
Management of Regional Lymph Nodes in Papillary, Follicular and Medullary Thyroid Cancer
INTRODUCTION
LYMPHATIC DRAINAGE OF THE THYROID
APPLIED SURGICAL ANATOMY
INCIDENCE AND LOCALIZATION OF LYMPH NODE METASTASES
Incidence
Localization
PROGNOSTIC SIGNIFICANCE OF REGIONAL LYMPH NODE METASTASES
Survival
Recurrence Rate
CHOICE OF NECK DISSECTION
Papillary and Follicular Thyroid Carcinoma
Medullary Thyroid Carcinoma
Sentinel Lymph Node Dissection
OPERATIVE TECHNIQUE
COMPLICATIONS OF NECK DISSECTION
THERAPEUTIC STRATEGY
Papillary and Follicular Thyroid Carcinoma
Medullary Thyroid Carcinoma
TREATMENT OF REGIONAL RECURRENCES IN THE NECK
SUMMARY AND CONCLUSION
CHAPTER 35:
Prophylactic Central Compartment Lymph Node Dissection for Papillary Thyroid Carcinoma
INTRODUCTION AND BACKGROUND
DEFINITIONS
RISKS AND BENEFITS: IS PROPHYLACTIC CENTRAL NODE DISSECTION REALLY NECESSARY?
Proponents of PCLND
Detractors of PCLND
PREOPERATIVE NODAL EVALUATION AND PATIENT SELECTION
SURGICAL ANATOMY OF THE CENTRAL NECK
OPERATIVE TECHNIQUE OF PCLND
MOLECULAR DIAGNOSTICS IN PCLND
CONCLUSION
CHAPTER 36:
Prophylactic Versus Therapeutic Central Lymph Node Dissection for Papillary Thyroid Cancer
INTRODUCTION
DEFINITION OF PROPHYLACTIC VERSUS THERAPEUTIC CENTRAL LYMPH NODE DISSECTION
THE EFFECT OF PROPHYLACTIC CENTRAL NECK DISSECTION ON SURVIVAL
THE ARGUMENTS FOR AND AGAINST PROPHYLACTIC CENTRAL NECK DISSECTION
The Incidence of Lymph Node Metastase in PTC
Preoperative and Intraoperative Evaluation of the Central Neck for Lymph Node Metastases
The Effect of pCLND on Cancer Recurrence and Postoperative Thyroglobulin Levels
The Morbidity of Central Neck Dissection
Central Neck Dissection and Tumor Staging
OUTCOMES WITH A SELECTIVE APPROACH TO CENTRAL NECK DISSECTION
SUMMARY AND RECOMMENDATIONS
CHAPTER 37:
Occurrence and Prevention of Complications in Thyroid Surgery
SURGERY FOR THYROID DISEASE
COMPLICATIONS IN PATIENTS UNDERGOING THYROID SURGERY
GENERAL COMPLICATIONS
SPECIFIC COMPLICATIONS
Edema
Bleeding
Wound Healing Disorders and Infection
Vascular and Lymphatic Lesions
Damage to the Recurrent Laryngeal Nerve
Damage to the External Branch of the Superior Laryngeal Nerve
Hypoparathyroidism
Hypothyroidism
SUMMARY
CHAPTER 38:
Thyroid Emergencies: Thyroid Storm and Myxedema Coma
CLINICAL MANIFESTATIONS
DIAGNOSIS
PATHOPHYSIOLOGY
TREATMENT
Antithyroid Therapy
Adrenergic Depletion
Treatment of Systemic Decompensation
Treatment of Coexistent Illness and Definitive Treatment
PREVENTION
CLINICAL MANIFESTATIONS
DIAGNOSIS
TREATMENT
Pulmonary and Cardiovascular Systems
Thyroid Hormone Replacement
Treatment of Metabolic Complications
Elimination of Precipitating Factors and Concurrent Illness
General Supportive Care
SUMMARY
CHAPTER 39:
Pathology of Tumors of the Thyroid Gland
CLASSIFICATION OF THYROID TUMORS
Follicular Lesions
Papillary Lesions
Trabecular and Solid Lesions
Spindle Cell and Squamoid Lesions
Small Cell Tumors
Cystic Lesions
CHAPTER 40:
Factors that Predispose to Thyroid Neoplasia
INTRODUCTION
RADIATION EXPOSURE
Historical Aspects
Childhood Radiation Exposure
Medical Care-Associated Radiation Exposure
Environmental Radiation Exposure
Molecular Carcinogenesis of Radiation-Induced Thyroid Cancer
FAMILY AND PERSONAL HISTORY
OTHER FACTORS
SUMMARY
CHAPTER 41:
Familial (Hereditary) Nonmedullary Thyroid Cancer
INTRODUCTION
DEFINITION OF FNMTC
IDENTIFYING FNMTC AS A DISTINCT GENETIC DISEASE
CLINICAL CHARACTERISTICS OF FNMTC
CLINICAL SCREENING GUIDELINES
FNMTC INHERITANCE PATTERN
GENETIC ANTICIPATION IN FNMTC
GENETICS OF FNMTC
Linkage Analysis
SNP Arrays
microRNA
Telomere Length
OTHER GENETIC SYNDROMES ASSOCIATED WITH NONMEDULLARY THYROID CANCER
Familial Adenomatous Polyposis
Cowden Syndrome (PTEN Hamartoma Syndrome)
Carney's Complex
Werner's Syndrome
Other Syndromes
ROLE OF GENETIC COUNSELING
CONCLUSION
CHAPTER 42:
Oncogenesis in Thyroid Nodules
INTRODUCTION
Multistep Carcinogenesis Model
Fetal Cell Carcinogenesis Model
Thyroid Cancer Stem Cells
GENETICS
BRAF
RAS
PAX8/PPARγ Rearrangement
RET/PTC Rearrangement
TRK
PTEN
TP53
CTNNB1
MICRORNAS
Biogenesis and Function of miRNAs
miRNAs as Diagnostic Markers
miRNAs as Prognostic Markers
miRNAs as Therapeutic Targets
EPIGENETICS
DNA Methylation
Histone Modifications
SIGNALING PATHWAY DEREGULATION
MAPK/ERK Signaling Pathway
PI3K-AKT Signaling Pathway
CONCLUSION
CHAPTER 43:
Molecular Classification of Thyroid Tumors
INTRODUCTION
PROTEIN MARKERS
Galectin-3
Hector Battifora Mesothelial-1
Cytokeratin-19
Cell Cycle Regulators
Matrix Metalloproteinase
Multimarker Immunohistochemical Combinations
Proteomic Studies
GENETIC MARKERS
BRAF Mutations
RET/PTC Rearrangements
RAS Mutations
PAX8/PPARγ Rearrangement
Mitochondrial DNA and Related Mutations
MicroRNAs
Multi-Gene Combination
SUMMARY
CHAPTER 44:
Oncogenesis and New Targeted Treatment for Thyroid Cancer
INTRODUCTION
GENETIC ALTERATIONS IN THYROID CANCER OF FOLLICULAR CELL ORIGIN
Transmembrane Receptor Proteins
Thyroid-Stimulating Hormone Receptor
Receptor Tyrosine Kinases
RET/Papillary Thyroid Cancer Oncogene
TRK Oncogene
MET Oncogene
c-erb-2 Oncogene
Oncogenic Intracellular Signaling Proteins
BRAF Oncogene
RAS Oncogene
Stimulatory GTP-binding Protein
Nuclear Oncogenes
PAX8/Peroxisome Proliferator-Activated Receptor γ Rearrangement
Tumor Suppressor Genes
TP53
Retinoblastoma Gene
Adenomatous Polyposis Coli
Multiple Tumor Suppressor (MTS1 and MTS2)
Phosphatase and Tensin Homolog
TARGETED THERAPY IN THYROID CANCER OF FOLLICULAR CELL ORIGIN
Tyrosine Kinase Inhibitors
Peroxisome Proliferator-Activated Receptor γ Agonists
Epigenetic Modulators
SUMMARY
CHAPTER 45:
Mechanisms and Regulation of Invasion in Thyroid Cancer
INTRODUCTION
GENETIC ALTERATIONS AND THE METASTATIC PROGRESSION OF THYROID CANCER
Oncogenes and Metastatic Thyroid Cancer
RET/PTC
RAS
PAX8/PPARgamma
P53
ECM DYNAMICS AND CANCER PROGRESSION
Composition and Properties of the ECM
MMPs, ADAMs, ADAMTSs, TIMPs, and Thyroid Cancer
Cathepsins, Cystatins, and Thyroid Cancer
INTRACELLULAR SIGNALING EVENTS MEDIATED VIA THE ECM PROTEINS, TGF-β INTEGRINS, MMPs, AND CATHEPSINS
ECM, EMT, INVASION, AND METASTASIS
CANCER STEM CELLS AND THYROID CANCER
CLINICAL THERAPEUTICS
SUMMARY
CHAPTER 46:
Radioactive Iodine Therapy: Mechanisms and Indications
INTRODUCTION
TARGETED DESTRUCTION OF THYROID CANCER CELLS WITH RADIOACTIVE IODINE
Iodine Metabolism in Thyroid Cancer Cells
Patient Preparation and Administered Activities
Adverse Effects
INDICATIONS AND CONTRAINDICATIONS
Normal Thyroid Remnant Ablation
Adjuvant Therapy
Ablation of Documented Foci of Gross Residual Disease
CONCLUSION
CHAPTER 47:
Recombinant Human TSH and Management of Differentiated Thyroid Cancer
BACKGROUND
HISTORICAL ASPECT
PRECLINICAL DATA
CLINICAL DATA—rhTSH AS A DIAGNOSTIC TOOL
Diagnostic Values and Limitations of rhTSH-Stimulated Tg
rhTSH as a Therapeutic Tool for Remnant Ablation
rhTSH as a Therapeutic Tool for Metastatic Disease
BIOKINETIC STUDIES OF RADIOIODINE WITH rhTSH VERSUS THW
ADVERSE EFFECTS AND PRECAUTIONS
CONCLUSION
CHAPTER 48:
Surgical Management of Recurrent and Retrosternal Goiters
INTRODUCTION
PREVALENCE
CAUSES OF RECURRENT GOITER
Incomplete Thyroidectomy
Total Thyroidectomy
Malignancy
Inadequate TSH Suppression Post-subtotal Thyroidectomy
CLINICAL PRESENTATION AND INDICATION FOR SURGERY
PREOPERATIVE ASSESSMENT
SURGICAL APPROACH
POSTOPERATIVE MANAGEMENT
COMPLICATIONS
CONCLUSION
INTRODUCTION
PREVALENCE
ETIOLOGY
PATHOLOGY
CLINICAL FEATURES
INDICATIONS FOR SURGERY
CLASSIFICATION
SURGICAL APPROACH
PREOPERATIVE INVESTIGATIONS AND ASSESSMENT
OPERATIVE TECHNIQUE
Cervical Approach
Sternotomy
POSTOPERATIVE MANAGEMENT
COMPLICATIONS
CONCLUSION
SUMMARY
CHAPTER 49:
Surgical Management of Advanced Thyroid Cancer Invading the Aerodigestive Tract
INTRODUCTION
PREOPERATIVE ASSESSMENT OF LOCAL AND DISTANT DISEASE
PATIENT SELECTION
Local Resectability
Progression of the Disease
Physical and Mental Condition of the Patient
SURGICAL APPROACH
Preparation of the Patient, Intubation and Skin Incision
Cervical Exploration
Surgical Technique of Radical Resection of Aerodigestive Invasion
LONG-TERM RESULTS AFTER SURGERY
SUMMARY
SECTION 2: PARATHYROID
CHAPTER 50:
Parathyroid Embryology, Anatomy, and Pathology
INTRODUCTION
EMBRYOLOGY
Preprimordial Stage
Early Primordial Stage
Branchial Complex Stage
Isolation Stage
Definitive Form Stage
ANATOMY
Relation between the Parathyroid Glands and the Recurrent Laryngeal Nerve
Arterial Blood Supply to the Parathyroids
PATHOLOGY
Adenoma
Adenoma Variants
Hyperplasia
Carcinoma
SUMMARY
CHAPTER 51:
Diagnosis of Primary Hyperparathyroidism and Indications for Parathyroidectomy
CLINICAL MANIFESTATIONS
LABORATORY INVESTIGATIONS
Normocalcemic Hyperparathyroidism
RADIOLOGIC INVESTIGATIONS
INDICATIONS FOR OPERATIVE TREATMENT AND RATIONALE FOR PARATHYROIDECTOMY
CONCLUSION
CHAPTER 52:
Natural History of Untreated Primary Hyperparathyroidism
INTRODUCTION
EPIDEMIOLOGY
FOLLOW-UP OF HEALTH SURVEY- DETECTED HYPERCALCEMIA
CONSERVATIVE FOLLOW-UP IN CLINICALLY DETECTED PRIMARY HYPERPARATHYROIDISM
LONG-TERM PROSPECTIVE FOLLOW-UP STUDY
PROGRESSION OF SYMPTOMS
Urinary Calcium Excretion/Renal Stones
Renal Function Impairment
Bone Disease
Neurocognitive Function
Cardiovascular Disease
RANDOMIZED CONTROLLED STUDIES ON THE TREATMENT OF MILD PHPT
SUMMARY
CHAPTER 53:
Metabolic Complications of Primary Hyperparathyroidism
INTRODUCTION
ARTERIAL HYPERTENSION
CARDIOVASCULAR DISEASE
PSYCHIATRIC AND COGNITIVE ASPECTS—QUALITY OF LIFE
NEUROMUSCULAR DISEASE
CARBOHYDRATE METABOLISM
LIPOPROTEIN METABOLISM
HYPERURICEMIA
CHONDROCALCINOSIS AND PSEUDOGOUT
SUMMARY
ACKNOWLEDGMENT
CHAPTER 54:
Natural History of Treated Primary Hyperparathyroidism
INTRODUCTION
GENERAL MEASURES
CINACALCET AND BISPHOSPHONATES
CONCLUSION
CHAPTER 55:
Asymptomatic Primary Hyperparathyroidism
HISTORY
THE CONCEPT OF “ASYMPTOMATIC” PHPT
ARE PATIENTS TRULY ASYMPTOMATIC?
HOW MIGHT SURGERY BENEFIT ASYMPTOMATIC PATIENTS WHO DO NOT MEET GUIDELINE CRITERIA FOR SURGERY?
Bone Loss
Renal Dysfunction
Cardiovascular Risk
Neurocognitive Symptoms
WHY NOT OPERATE ON EVERY PATIENT WITH PHPT?
Cost
Time
Risk
SUMMARY
CHAPTER 56:
Normocalcemic Hyperparathyroidism
INTRODUCTION
CALCIUM HOMEOSTASIS AND PATHOPHYSIOLOGY OF NCPHP
DIAGNOSIS OF NCPHP
CLINICAL SYMPTOM PROFILES IN NCPHP
NATURAL HISTORY
MANAGEMENT
SUMMARY
CHAPTER 57:
Medical Management of Primary Hyperparathyroidism
INTRODUCTION
DRUG THERAPY
Failed Attempts
Therapeutic Options in Current Use
Estrogen
Raloxifene
Bisphosphonates
Calcimimetics
Combination Therapy
MANAGEMENT AND MEDICAL FOLLOW-UP OF PATIENTS NOT UNDERGOING SURGERY FOR PHPT
UNIQUE CLINICAL SITUATIONS
Parathyroid Carcinoma
MEN1
Neonatal Hyperparathyroidism
SUMMARY AND OVERALL THERAPEUTIC STRATEGY
CHAPTER 58:
Localization Studies in Primary Hyperparathyroidism
INTRODUCTION
ANATOMY AND EMBRYOLOGY
PREOPERATIVE LOCALIZATION
Noninvasive Imaging
Ultrasound
Scintigraphy
Positron Emission Tomography
Computed Tomography
Magnetic Resonance Imaging
Invasive Localization
INTRAOPERATIVE LOCALIZATION
Radio-Guided Surgery
Intraoperative Ultrasound
Intraoperative Parathyroid Aspiration
Methylene Blue
COMPARISON OF ALTERNATIVE PREOPERATIVE IMAGING MODALITIES
CONCLUSION
CHAPTER 59:
Localization Studies in Persistent or Recurrent Hyperparathyroidism
NONINVASIVE PREOPERATIVE METHODS
Ultrasonography
Computed Tomography
Magnetic Resonance Imaging
Thallium-Technetium Scan
Technetium 99m Sestamibi Scintigraphy
INVASIVE PREOPERATIVE METHODS
Fine-Needle Aspiration
Parathyroid Arteriography
Selective Venous Sampling for Parathyroid Hormone Assay
INTRAOPERATIVE LOCALIZATION METHODS
Intraoperative US
Radio-Guided Parathyroid Surgery
Intraoperative PTH
CONCLUSION
CHAPTER 60:
Technique of Parathyroidectomy
INTRODUCTION
A BRIEF HISTORY OF PARATHYROID SURGERY
PARATHYROID EMBRYOLOGY
PARATHYROID ANATOMY
PREOPERATIVE LOCALIZATION
PREINCISION OR POSTINCISION LOCALIZATION
SELECTION OF UNILATERAL OR BILATERAL APPROACH
CONVENTIONAL PARATHYROIDECTOMY
THE IDENTIFICATION OF ABNORMAL PARATHYROID TISSUE
MANEUVERS TO EXPOSE A MISSING UPPER GLAND
MANEUVERS TO EXPOSE A MISSING LOWER GLAND
TECHNIQUE OF PARATHYROID RESECTION
RESECTION OF PARATHYROID CARCINOMA
CONFIRMATION OF CURATIVE RESECTION
SURGICAL TECHNIQUE OF REOPERATIVE PARATHYROID SURGERY
CRYOPRESERVATION
PARATHYROIDECTOMY UNDER REGIONAL ANESTHESIA
CONCLUSION
CHAPTER 61:
Surgical Approach to Primary Hyperparathyroidism (Bilateral Exploration)
INTRODUCTION
CLINICAL PRESENTATION
BIOCHEMICAL DIAGNOSIS
INDICATIONS FOR AND OUTCOMES OF SUCCESSFUL PARATHYROIDECTOMY
LOCALIZATION STUDIES FACILITATING INTENT OF INITIAL SURGICAL APPROACH
RATIONALE AND OUTCOMES OF BILATERAL VERSUS FOCAL EXPLORATION
BILATERAL PARATHYROID EXPLORATION
Relevant Anatomy and Embryology
Surgical Technique
Postoperative Management
CONCLUSION
CHAPTER 62:
Surgical Approach to Primary Hyperparathyroidism (Unilateral Approach)
INTRODUCTION
TERMS AND DEFINITIONS
INDICATIONS FOR A UNILATERAL APPROACH TO PARATHYROIDECTOMY
WORKUP AND PREOPERATIVE RADIOGRAPHIC LOCALIZATION
ANATOMIC CONSIDERATIONS
OPERATIVE TECHNIQUE
Patient Positioning and Anesthesia
Anterior Approach
Lateral Approach
Dissection and Excision of the Adenoma
Closure
ROLE OF INTRAOPERATIVE PARATHYROID HORMONE MEASUREMENT
POSTOPERATIVE CARE AND FOLLOW-UP
RESULTS OF UNILATERAL PARATHYROIDECTOMY
SUMMARY
CHAPTER 63:
Minimally Invasive Video-Assisted Parathyroidectomy
INTRODUCTION
INDICATIONS FOR MIVAP
MIVAP: SURGICAL PROCEDURE
Patients and Surgical Team Position
Anesthesia
Surgical Technique
RESULTS OF MIVAP
ADVANTAGES AND DISADVANTAGES OF MIVAP
MIVAP: EVIDENCE-BASED RECOMMENDATIONS
CONCLUSION
CHAPTER 64:
Minimally Invasive Parathyroid Exploration
INTRODUCTION
SPECIFIC APPROACHES TO FOCUSED/MINIMALLY INVASIVE PARATHYROID SURGERY (F/MP)
IOPTH MONITORING
PERIOPERATIVE MANAGEMENT OF F/MP
Preoperative Evaluation
F/MP Indications and Contraindications
Preoperative Imaging
Technique of F/MP
Complex F/MP
Video-Assisted F/MP
Cervical Block Anesthesia
Postoperative Management and Outcomes
F/MP PITFALLS
CONCLUSION
CHAPTER 65:
Endoscopic Parathyroidectomy
INTRODUCTION
TECHNIQUE OF EPLA
INDICATIONS AND CONTRAINDICATIONS
RESULTS
EXPERIENCE WITH EPLA
CONCLUSION
CHAPTER 66:
Intraoperative Parathormone Assay as a Surgical Adjunct in Patients with Sporadic Primary Hyperparathyroidism
INTRODUCTION
SURGICAL CANDIDATES FOR IPM-GUIDED PARATHYROIDECTOMY
RATIONALE AND USE OF THE INTRAOPERATIVE PTH ASSAY
ESTABLISHED “MIAMI CRITERION” FOR EVALUATION OF INTRAOPERATIVE PTH LEVELS
INTERPRETATION OF INTRAOPERATIVE PTH DYNAMICS
PRACTICAL CONSIDERATIONS OF INTRAOPERATIVE PTH MONITORING
ADDITIONAL USES FOR THE INTRAOPERATIVE PTH ASSAY
Differential Internal Jugular Venous Sampling
Biochemical FNA
PARATHYROIDECTOMY GUIDED BY INTRAOPERATIVE PTH MONITORING
IPM-Guided Parathyroidectomy and Bilateral Neck Exploration
Intraoperative PTH Monitoring and Equivocal/Discordant or Negative Localization Studies
Intraoperative PTH Monitoring and Multiglandular Disease
Intraoperative PTH Monitoring and Stricter Criteria
Results of IPM-Guided Parathyroidectomy
Intraoperative PTH Monitoring and Miami Criterion Accuracy
CONCLUSION
CHAPTER 67:
Parathyroid Hyperplasia: Parathyroidectomy
INTRODUCTION
EMBRYOLOGY AND ANATOMY OF PARATHYROID GLAND
PARATHYROID MORPHOLOGY
ETIOLOGY OF HYPERPLASIA
INDICATIONS FOR PARATHYROIDECTOMY
OPERATIVE TREATMENT
OPERATIVE TECHNIQUE
TOTAL PARATHYROIDECTOMY AND AUTOTRANSPLANTATION
CRYOPRESERVATION OF PARATHYROID TISSUE
MEDICAL TREATMENT VERSUS SURGICAL MANAGEMENT
LONG-TERM RESULTS OF DIFFERENT TECHNIQUES
SUMMARY
CHAPTER 68:
Familial Hyperparathyroidism in Multiple Endocrine Neoplasia Syndromes
INTRODUCTION
CLINICAL ASPECTS
DIAGNOSIS
TREATMENT
FOLLOW-UP AND SCREENING
INTRODUCTION
DIAGNOSIS
FOLLOW-UP AND SCREENING
SUMMARY
CHAPTER 69:
Familial Hyperparathyroidism
INTRODUCTION
NON-MEN FAMILIAL HPT (FAMILIAL ISOLATED HPT)
Clinical Features
Associated Diseases
Persistent or Recurrent Hyperparathyroidism
Surgical Treatment
Key Points for Differential Diagnosis
NMFH with Parathyroid Cancer
Review of 15 Cases of NMFH and Parathyroid Cancer Reported until 2002
FAMILIAL NEONATAL HPT
SUMMARY
CHAPTER 70:
Secondary Hyperparathyroidism: Pathogenesis, Metabolic Complications, and Surgical Approach
INTRODUCTION
PATHOGENESIS OF SHPT
Diminished Synthesis of Calcitriol
Phosphate Retention
Hypocalcemia
CLINICAL MANIFESTATIONS OF SHPT
Bone Disease
Extraskeletal Calcification
Pruritus
Calciphylaxis
Clinical Manifestations of SHPT after Kidney Transplantation
INDICATIONS FOR SURGERY
Pretransplant
Post-Transplant
Transient Hypercalcemia
Persistent Hypercalcemia
Relapsing Hypercalcemia
PREOPERATIVE CARE
LOCALIZATION STUDIES
SURGICAL MANAGEMENT
Extent of the Surgical Procedure
Subtotal Parathyroidectomy
Total Parathyroidectomy and Autotransplantation
Total Parathyroidectomy without Transplantation
COMPLICATIONS OF PTX
Transient Hypocalcemia
Permanent Hypoparathyroidism
Persistence and Recurrence
CLINICAL COURSE AFTER SUCCESSFUL PTX
SUMMARY
CHAPTER 71:
Surgical Treatment of Persistent Hyperparathyroidism after Renal Transplantation
INTRODUCTION
Pathophysiology of Hyperparathyroidism in Chronic Kidney Disease (See also Chapter 74)
Persistent Hyperparathyroidism after Kidney Transplantation
Implications of Persistent Hyperparathyroidism
Hypercalcemia
Hypophosphatemia
Renal Allograft Dysfunction
Bone Health
Medical Management of Persistent Hyperparathyroidism after Renal Transplantation
EPIDEMIOLOGY, INDICATION, AND TIMING OF POST-TRANSPLANT PARATHYROIDECTOMY
PREOPERATIVE IMAGING
SURGICAL TREATMENT OF PERSISTENT HYPERPARATHYROIDISM AFTER RENAL TRANSPLANTATION
Extent of Surgery
Cryopreservation
Role of Simultaneous Thymectomy
Utility of Intraoperative PTH Monitoring
Use of Intraoperative Histopathology
Surgical Complications
OUTCOME
Characteristics of Bone Mineral Metabolism
Graft Function/Graft Survival
CONCLUSION
CHAPTER 72:
Vitamin D and Fibroblast Growth Factor 23 in Parathyroid Disease
INTRODUCTION
PARATHYROID HORMONE
Mechanism of Action
Regulation of PTH Synthesis and Secretion
Calcium and Phosphate Regulation
FGF23 Regulation
Vitamin D Regulation
FGF23
Mechanism of Action (Fig. 72.2)
Regulation of FGF23 Synthesis and Secretion
Regulation by 1,25(OH)2D
Regulation by Phosphate
Regulation by PTH
1,25(OH)2D
Mechanism of Action
Regulation of Production and Secretion
VITAMIN D AND PARATHYROID DISEASES
Primary Hyperparathyroidism and Vitamin D Deficiency
Secondary Hyperparathyroidism and CKD
Hypoparathyroidism
CHAPTER 73:
Parathyroid Reoperations
INTRODUCTION
CAUSES OF FAILED INITIAL EXPLORATION FOR HYPERPARATHYROIDISM
APPROACH TO THE REOPERATIVE PATIENT
Confirmation of Diagnosis
Evaluation of Indications versus Risk of Reoperation
Review Previous Operative Notes and Pathology Reports
Consider Alternative Therapeutic Modalities: Medical versus Ablative Therapy
Plan Appropriate Cost-Effective Localizing Modalities
OPERATIVE ASPECTS
Cervical Exploration
Mediastinal Exploration
Intraoperative Localization
Cryopreservation and Autotransplantation
BRIEF REVIEW OF RESULTS OF REOPERATIVE PARATHYROID SURGERY
ILLUSTRATIVE CASES
Case 1
Case 2
REOPERATIVE PEARLS
SUMMARY
CHAPTER 74:
Hypoparathyroidism and Pseudohypoparathyroidism
POSTSURGICAL HYPOPARATHYROIDISM
MANAGEMENT OF HYPOPARATHYROIDISM
PSEUDOHYPOPARATHYROIDISM
SUMMARY
CHAPTER 75:
Cryopreservation of Parathyroid Tissue
OVERVIEW
INDICATIONS
Initial Neck Operations
Redo Neck Operations
CRYOPRESERVATION TECHNIQUES
Tissue Preparation
Freezing Media
Freezing Process
AUTOTRANSPLANTATION TECHNIQUES
Thawing
Reimplantation
POST-TRANSPLANT FUNCTIONALITY TESTING
EFFECTS OF CRYOPRESERVATION
SUMMARY
CHAPTER 76:
Hypercalcemia of Malignancy and Parathyroid Hormone-Related Protein
TUMORS CAUSING HYPERCALCEMIA
PATHOGENESIS OF HYPERCALCEMIA
Humoral Hypercalcemia—Parathyroid Hormone-Related Protein
Humoral Hypercalcemia—1,25-Dihydroxy Vitamin D
Humoral Hypercalcemia—Parathyroid Hormone
Local Osteolytic Hypercalcemia
CLINICAL CONSIDERATIONS
Differential Diagnosis and Tests
Treatment
SUMMARY
CHAPTER 77:
Hypercalcemic Crisis
INTRODUCTION
INCIDENCE AND ETIOLOGY OF HYPERCALCEMIC CRISIS
CLINICAL FEATURES OF HYPERCALCEMIC CRISIS
DIAGNOSIS
HYPERCALCEMIC CRISIS IN PREGNANCY
TREATMENT
SUMMARY
CHAPTER 78:
Parathyroid Carcinoma
INTRODUCTION
INCIDENCE AND PREVALENCE
CLINICAL PRESENTATION
DIAGNOSIS
Laboratory
Imaging
Pathology
The Role of FNA
Gross Pathology
Histology
Genetic Markers
TREATMENT/OPERATIVE FINDINGS
Surgical Treatment
Initial Neck Exploration
Recurrence
Medical Treatment
Parathyrotoxicosis
Chemotherapy/Radiation Therapy
Palliative/Emerging Therapy
PROGNOSIS
SUMMARY
CHAPTER 79:
Molecular Tests for Parathyroid Carcinomas
INTRODUCTION
MOLECULAR MARKERS FOR DETECTION OF PC AND OTHER RELATED DISEASES
PC ASSOCIATED WITH FAMILIAL FORMS OF PHPT
HEREDITARY HYPERPARATHYROIDISM-JAW TUMOR SYNDROME
FAMILIAL ISOLATED HYPERPARATHYROIDISM
PARATHYROID CARCINOMA
GENETIC COUNSELING AND EVALUATION OF RELATIVES AT RISK
Parents of a Proband
Siblings of a Proband
Prenatal and Other Family Members of a Proband
CLOSE SURVEILLANCE AND FOLLOW-UP25
PARAFIBROMIN IMMUNOSTAINING
ADDITIONAL MOLECULAR MARKERS
Ki-67
Galectin-3
Cyclin D1
Retinoblastoma
P27
MicroRNA Profiling
PGP9.5
Human Telomerase Reverse Transcriptase
E-cadherin/Snail/Twist
APC
Other Notable Markers
LABORATORY MARKERS
Parathyroid Hormone and Calcium
Serum Alkaline Phosphatase
Serum Human Chorionic Gonadotropin
SUMMARY
SECTION 3: ADRENAL GLAND
CHAPTER 80:
Surgical Embryology and Anatomy of the Adrenal Glands
HISTORICAL BACKGROUND
EMBRYOLOGY
Embryology of the Adrenal Medulla
DEVELOPMENT OF ADRENAL ARTERIES
EMBRYOLOGY AND STEROIDOGENESIS
CLINICAL ASPECTS
ACCESSORY TISSUE
ANATOMY
MACROSCOPIC ASPECT
RELATIONS
ARTERIAL SUPPLY
VENOUS DRAINAGE
LYMPHATIC DRAINAGE
NERVE SUPPLY
MICROSCOPIC ANATOMY
IMAGING
Radionuclide Imaging
SURGICAL APPLICATIONS
OPEN ADRENALECTOMY
Posterior Approach
Anterior Approach
Left Adrenalectomy
Right Adrenalectomy
Laparoscopic Adrenalectomy
Retroperitoneoscopic Adrenalectomy
SUMMARY
CHAPTER 81:
Adrenal Physiology
INTRODUCTION
ADRENAL CORTEX
Functional Morphology
Biosynthesis of Corticosteroids
Aldosterone
Cortisol
Sex Steroids
Physiologic Effects of Corticosteroids
Aldosterone
Cortisol
Adrenal Androgens
ADRENAL MEDULLA
Chromaffin Cells
Transmitter Mechanisms
Biosynthesis of Catecholamines
Secretion
Degradation
DETERMINATION OF RELEASE FROM THE ADRENAL MEDULLA
PHYSIOLOGIC EFFECTS
SUMMARY
CHAPTER 82:
Modalities for Imaging the Adrenal Gland
INTRODUCTION
COMPUTED TOMOGRAPHY
MAGNETIC RESONANCE IMAGING
NUCLEAR MEDICINE STUDIES
ADRENAL INCIDENTALOMA
FUNCTIONAL ADRENAL ADENOMA
Hypercortisolism
Aldosterone Secreting Adenoma
CATECHOLAMINE SECRETING TUMORS
ADRENOCORTICAL CARCINOMA
SUMMARY
CHAPTER 83:
Adrenal Venous Sampling
INTRODUCTION
INDICATIONS
COMPLICATIONS
TECHNICAL CONSIDERATIONS
Procedure Description
INTERPRETATION OF THE RESULTS
Confirmation of Cannulation of Adrenal Vein
Distinguishing Hypersecreting and Suppressed Adrenal Tissue
CONCLUSION
CHAPTER 84:
Adrenal Incidentaloma
INTRODUCTION
FREQUENCY
PATHOLOGY
THE GOAL OF EVALUATION
Function
Malignancy
SCREENING FOR SCS
SCREENING FOR “SUBCLINICAL PHEOCHROMOCYTOMA”
SCREENING FOR “SUBCLINICAL PRIMARY ALDOSTERONISM”
SCREENING FOR ADRENAL CARCINOMA
SIZE OF TUMOR
IMAGING
FINE-NEEDLE ASPIRATION
GENETIC AND MOLECULAR BIOLOGY STUDIES
MANAGEMENT OF INCIDENTALOMA: SURGERY VERSUS FOLLOW-UP
WHAT IS THE BEST SURGICAL APPROACH IN THE MANAGEMENT OF ADRENAL INCIDENTALOMAS?
WHICH LAPAROSCOPIC APPROACH?
SUMMARY
CHAPTER 85:
Hyperaldosteronism
PATHOLOGIC FEATURES
FAMILIAL AND DE NOVO MUTATIONS IN HYPERALDOSTERONISM
BIOCHEMICAL TESTING
CONFIRMATORY TESTING
LOCALIZATION STUDIES
CT Imaging
Adrenal Vein Sampling
TREATMENT
OUTCOMES
SUMMARY
CHAPTER 86:
Adrenocortical Carcinoma: Nonfunctioning and Functioning
INTRODUCTION
INCIDENCE
CLINICAL AND BIOCHEMICAL TESTS SUGGESTING MALIGNANCY
CRITERIA OF MALIGNANCY OF CORTICAL TUMORS
CLINICAL PRESENTATION
PREOPERATIVE IMAGING AND SUSPICION OF MALIGNANCY
STAGING, SURGICAL INDICATIONS, AND PREOPERATIVE TREATMENT
MACROSCOPIC MORPHOLOGY, PREOPERATIVE IMAGING, AND SURGICAL STRATEGY
SURGICAL STRATEGY AND TECHNICAL OPERATIVE RISKS
SPECIFIC POSTOPERATIVE CARE
OVERALL RESULTS AND PROGNOSTIC FACTORS
SURGERY OF METASTASES AND RECURRENCES
ADJUVANT THERAPY
ADRENOCORTICAL CARCINOMA IN CHILDHOOD
SUMMARY
CHAPTER 87:
Cushing's Syndrome
INTRODUCTION
EPIDEMIOLOGY AND PATHOGENESIS
CLINICAL FEATURES
DIAGNOSTIC PROCEDURES
LOCALIZING PROCEDURES
TREATMENT
Pituitary-Dependent Cushing's Syndrome
Ectopic Corticotropin Syndrome
Adrenal Adenomas
Adrenal Carcinoma
Primary Adrenal Hyperplasia
SUMMARY
CHAPTER 88:
Pheochromocytoma
HISTORY
INCIDENCE
CLINICAL FEATURES
DIAGNOSIS
LOCALIZATION
Computed Tomography
Magnetic Resonance Imaging
Metaiodobenzylguanidine Scintigraphy
Positron Emission Tomography/CT
PREOPERATIVE MANAGEMENT
INTRAOPERATIVE MANAGEMENT
OPERATIVE TECHNIQUE
Laparoscopic Approach
Anterior Approach
Right Adrenal
Left Adrenal
PARAGANGLIOMAS
POSTOPERATIVE MANAGEMENT
PATHOLOGY AND MALIGNANCY
SPECIAL CIRCUMSTANCES
Pregnancy
Children
HERITABLE PHEOCHROMOCYTOMA SYNDROMES
Multiple Endocrine Neoplasia
von Hippel-Lindau Disease
Neurofibromatosis
Paraganglioma Syndromes
PGL1
PGL2
PGL3
PGL4
CONCLUSION
CHAPTER 89:
Adrenal Insufficiency
INTRODUCTION
PRIMARY ADRENAL INSUFFICIENCY
Pathophysiology
Clinical Findings
Diagnosis
Treatment
BILATERAL ADRENAL HEMORRHAGE
DRUGS
SECONDARY AND TERTIARY ADRENAL INSUFFICIENCY
CHRONIC STEROID USE
Pathophysiology
Clinical Findings
Diagnosis
Treatment
Chronic Treatment
Perioperative Considerations
PITUITARY ADRENAL AXIS DISEASE
STRESS-INDUCED ADRENAL INSUFFICIENCY AND ACUTELY ILL PATIENTS
Relative Adrenal Insufficiency in Critically Ill Patients
Trauma Patients
Taxed Adrenal Reserve
New Recognition of Perioperative Adrenal Insufficiency
SUMMARY
CHAPTER 90:
Open Operative Approaches to the Adrenal Gland
INTRODUCTION
SURGICAL ANATOMY
Right Adrenal
Left Adrenal
Preoperative Preparation
CHOICE OF PROCEDURE
Anterior Approach
Anterior Exposure and Mobilization of the Right Adrenal Gland
Anterior Exposure and Mobilization of the Left Adrenal Gland
Pearls and Pitfalls—Anterior Adrenalectomy
Thoracoabdominal/Lateral Transthoracic Approach
Posterior Approach
Flank Approach
Conversion to Open Adrenalectomy
SUMMARY
CHAPTER 91:
Robot-Assisted Adrenalectomy
INTRODUCTION
TECHNICAL ASPECTS
FEASIBILITY, LEARNING CURVE, AND OUTCOMES
COMPARISON OF RA TO LAPAROSCOPIC ADRENALECTOMY (TRANSPERITONEAL)
ROBOTIC PARTIAL ADRENALECTOMY
BILATERAL RA
PARAGANGLIOMA ROBOTIC RESECTION
ADRENOCORTICAL CARCINOMA
POSTERIOR ROBOTIC ADRENALECTOMY
COST
CONCLUSION
CHAPTER 92:
Laparoscopic Adrenalectomy—Transperitoneal Approach
INTRODUCTION
INDICATIONS
PREOPERATIVE EVALUATION AND PREPARATION FOR SURGERY
Functional Cortical Tumors
Primary Hyperaldosteronism
Hypercortisolism due to Cushing's Syndrome
Functional Medullary Tumors
Pheochromocytoma
Nonfunctioning Adrenal Tumors
Adrenal Incidentaloma
Metastases
TECHNIQUES FOR TRANSPERITONEAL LAPAROSCOPIC ADRENALECTOMY
Operative Technique
Surgical Equipment
Patient Preparation and Positioning
Port Placement and Creation of Pneumoperitoneum
RIGHT ADRENALECTOMY
LEFT ADRENALECTOMY
PEARLS AND PITFALLS
CHAPTER 93:
Posterior Retroperitoneoscopic Adrenalectomy (PRA)
INTRODUCTION
INDICATIONS FOR PRA
CONVENTIONAL SURGICAL TECHNIQUE (CORA) OF PRA
SINGLE ACCESS RETROPERITONEOSCOPIC ADRENALECTOMY (SARA) OF PRA
POSTOPERATIVE TREATMENT
RESULTS OF PRA
SUMMARY
SECTION 4: ENDOCRINE PANCREAS
CHAPTER 94:
Anatomy and Embryology of the Pancreas
INTRODUCTION
EMBRYOLOGY
ANATOMY OF THE PANCREAS
Divisions of the Pancreas
Arterial Supply and Venous Drainage of the Pancreas
Anomalous Arterial Supply
Ducts of the Pancreas
Lymphatic Drainage
Nerves of the Pancreas
SURGICAL EXPOSURE OF THE PANCREAS
SUMMARY
CHAPTER 95:
Multiple Endocrine Neoplasia Type 1
INTRODUCTION
EPIDEMIOLOGY/CLINICAL PRESENTATION
THE MOLECULAR BIOLOGY OF MEN 1
WHO SHOULD BE CONSIDERED FOR GENETIC COUNSELING AND TESTING?
PITUITARY TUMORS
PRIMARY HYPERPARATHYROIDISM (HPT)
DIAGNOSIS
LOCALIZATION STUDIES
MANAGEMENT OF MEN 1 HPT
OPERATIVE APPROACH
PERSISTENT/RECURRENT HPT IN MEN 1 PATIENTS
OPERATIVE APPROACH IN PERSISTENT/RECURRENT HPT MEN 1 PATIENTS
RESULTS OF REOPERATIVE SURGERY (TABLE 95.6)
PANCREATIC/DUODENAL NEUROENDOCRINE TUMORS
Background
Biochemical Screening (Table 95.7)
IMAGING
WHO SHOULD UNDERGO SURGERY? (TABLE 95.8)
HYPOGLYCEMIC SYNDROME
OTHER PNETs
The Zollinger-Ellison Syndrome
Adrenal Neoplasia/Hyperplasia
Carcinoid Tumors
SUMMARY
CHAPTER 96:
Transplantation of Endocrine Tissues
INTRODUCTION
HUMAN ISLET TRANSPLANTATION
HUMAN PARATHYROID AUTOGRAFTS
OUR TECHNIQUE OF PARATHYROID TRANSPLANTATION
HUMAN PARATHYROID ALLOTRANSPLANTATION
CHAPTER 97:
Pancreatic Endocrine Physiology
HISTORICAL BACKGROUND
ISLET FUNCTION
ISLET ANATOMY
ISLET VASCULATURE
BETA CELLS
Insulin
Amylin
Pancreastatin
Nerve Growth Factor
ALPHA CELLS
Glucagon
Peptide YY
DELTA CELLS
Somatostatin
Diazepam-Binding Inhibitor
VIP
EPSILON CELLS
Ghrelin
F CELLS
Pancreatic Polypeptide
Adrenomedullin
ISLET INNERVATION
Sympathetic Innervation
Parasympathetic Innervation
Sensory Nerves
GASTROINTESTINAL PEPTIDES
Cholecystokinin
Gastrointestinal Incretins
CELLULAR MECHANISM OF INSULIN SECRETION
INSULIN SECRETION PATTERN
BETA CELLS AND TYPE 2 DIABETES
ENDOCRINE PANCREAS AND STRESS
Physical Exercise
Hypovolemic Shock
SUMMARY
CHAPTER 98:
Insulinomas
INTRODUCTION
HISTORICAL BACKGROUND
INCIDENCE AND DEMOGRAPHICS
MEN 1 SYNDROME
INSULIN-SECRETION FROM THE PANCREAS
CONTROL OF GLUCOSE HOMEOSTASIS
PHYSIOLOGIC RESPONSES TO HYPOGLYCEMIA
SIGNS AND SYMPTOMS OF AN INSULINOMA
DIFFERENTIAL DIAGNOSIS OF HYPOGLYCEMIA
DIAGNOSIS OF AN INSULINOMA
Whipple's Triad
Modern Diagnosis of an Insulinoma (Table 98.4)
Fasting Test
INTERPRETATION OF THE FASTING TEST (TABLE 98.4)
Plasma Insulin Concentrations
Plasma C Peptide and Proinsulin Concentrations
Beta-Hydroxybutyrate
Screening for Oral Hypoglycemic Agents
PROVOCATIVE TESTS
Glucagon Test
Glucose Tolerance Test
Calcium Infusion Test
PATHOLOGY OF INSULINOMAS
PREOPERATIVE LOCALIZATION STUDIES
Transcutaneous Ultrasonography
Computed Tomography
Magnetic Resonance Imaging
Angiography
Percutaneous Transhepatic Portal Venous Sampling
Arterial Stimulation and Venous Sampling (ASVS)
Isotope-Labeled Somatostatin Scanning
Positive Emission Tomography Scanning for Insulinomas
Endoscopic Ultrasound
Intraoperative Ultrasonography
Intraoperative Palpation
ARE PREOPERATIVE LOCALIZATION TESTS BENEFICIAL?
COST-EFFECTIVE APPROACH TO LOCALIZATION OF AN INSULINOMA
PERIOPERATIVE MANAGEMENT OF SERUM GLUCOSE
Preoperative Management
Intraoperative Management
Postoperative Management
OPERATIVE APPROACH
LAPAROSCOPIC RESECTION
COMPLICATIONS OF REMOVAL OF INSULINOMA
CAUSES OF HYPOGLYCEMIA AND HYPERINSULINEMIA THAT ARE NOT DUE TO AN INSULINOMA
Adult Nesidioblastosis and Noninsulinoma Pancreatogenous Hypoglycemia Syndrome
HYPOGLYCEMIA FOLLOWING ROUX-EN-Y GASTRIC BYPASS FOR OBESITY
MEDICAL THERAPY FOR HYPOGLYCEMIA
Diazoxide
Octreotide
Lanreotide
Verapamil
OTHER THERAPEUTIC APPROACHES FOR METASTATIC DISEASE63,64
Everolimus
SUMMARY
ACKNOWLEDGMENTS
CHAPTER 99:
Localization of Endocrine Pancreatic Tumors
INTRODUCTION
IMAGING TECHNIQUES
RADIOPHARMACEUTICAL IMAGING
In-111 Pentetreotide (Octreoscan)
GA-68 DOTATOC/TATE/NOC
Arterial Stimulation and Venous Sampling (ASVS)
INSULINOMAS
Illustrative Case 1
GASTRINOMAS
MEN1
Illustrative Case 2
NONFUNCTIONING PNET
SUMMARY
CHAPTER 100:
Pancreatic Surgery for Endocrine Tumors
INTRODUCTION
GENERAL PRINCIPLES OF PANCREATIC SURGERY FOR ENDOCRINE TUMORS
SURGERY FOR GASTRINOMA
SURGERY FOR INSULINOMA
SURGERY FOR NONFUNCTIONING TUMORS
MINIMALLY INVASIVE APPROACHES
EXTENT OF RESECTION
LYMPH NODE BIOPSY/DISSECTION
PANCREATIC SURGERY IN MEN 1
SURGERY FOR ADVANCED DISEASE
LIVER TRANSPLANTATION
SUMMARY
CHAPTER 101:
Gastrinoma
INTRODUCTION
HISTORY
CLINICAL PRESENTATION
GENOMIC ALTERATIONS
DIAGNOSIS
Differential Diagnosis
Biochemical Evaluation
Provocative Tests
Tumor Markers
Imaging
Endoscopy
TREATMENT
Localized Disease
Advanced Disease
CHAPTER 102:
Multiple Endocrine Neoplasia Type 2A
EPIDEMIOLOGY AND RISK FACTORS
CLINICAL PRESENTATION
DIAGNOSIS AND EVALUATION
Medullary Thyroid Cancer
Pheochromocytoma
Primary Hyperparathyroidism
Molecular Genetic Testing
MANAGEMENT
SURVEILLANCE
Preoperative Screening
Postoperative Follow-Up
PROGNOSIS
CONCLUSION
ACKNOWLEDGMENT
CHAPTER 103:
Multiple Endocrine Neoplasia Type 2B
INTRODUCTION
HISTORY
GENETICS AND PATHOPHYSIOLOGY
CLINICAL PRESENTATION AND DIAGNOSIS
Endocrine Phenotype
Nonendocrine Phenotype
SCREENING
SURGICAL TREATMENT
Medullary Thyroid Cancer
Asymptomatic Medullary Thyroid Cancer
Surgery for Clinically Apparent Medullary Thyroid Cancer
Pheochromocytoma
Pseudo-Hirschsprung's Disease
CLINICAL OUTCOME
CHAPTER 104:
Somatostatinoma and Rare Pancreatic Endocrine Tumors
GENERAL COMMENTS
PATHOLOGY
MULTIPLE ENDOCRINE NEOPLASIA TYPE 1
SURGICAL PRINCIPLES
SOMATOSTATINOMA
VIPoma
GLUCAGONOMA
GRFoma
CORTICOTROPIN-PRODUCING TUMOR
TUMOR RELEASING PARATHYROID HORMONE-RELATED PROTEIN
NEUROTENSINOMA
GHRELINOMA
PPoma AND NONFUNCTIONING NEUROENDOCRINE TUMORS
RARE POSSIBLE FUNCTIONAL PANCREATIC NEUROENDOCRINE TUMORS
SUMMARY
CHAPTER 105:
Non-Multiple Endocrine Neoplasia Endocrine Syndromes
SUMMARY
CHAPTER 106:
Endocrine Emergencies: Hypoglycemic and Hyperglycemic Crises
INTRODUCTION
OVERVIEW OF GLUCOSE METABOLISM
Hormonal Regulation
HYPERGLYCEMIC CRISES
Presentation
Pathogenesis
Diagnosis
Treatment
Fluids
Insulin
Other Electrolyte Abnormalities
HYPOGLYCEMIC CRISES
Ill or Medicated Patients
Well Patients
Diagnosis and Treatment
CONCLUSION
CHAPTER 107:
Ethical Issues in Endocrine Surgery
INTRODUCTION TO SURGICAL ETHICS
INFORMED CONSENT
SURGICAL INNOVATION AND SURGICAL RESEARCH
GENETIC TESTING AND PROPHYLACTIC SURGERY
CONCLUSION
CHAPTER 108:
Surgical Treatment of Endocrine Disease During Pregnancy
THYROID
Maternal Hyperthyroidism
Incidence and Epidemiology
Diagnosis of Hyperthyroidism
Medical and Surgical Treatment
Thyroid Nodules and Cancer
Incidence and Epidemiology
Evaluation of a Thyroid Nodule
Thyroid Cancer
Thyroid Suppression for Thyroid Cancer
PARATHYROID
Timing of Surgery
ADRENAL
CONCLUSION
CHAPTER 109:
Targeted Chemotherapy for Metastatic Endocrine Cancers
INTRODUCTION
THYROID CANCER
PARATHYROID CANCER
CANCER OF THE ADRENAL GLAND
PANCREATIC NEUROENDOCRINE CANCERS (PNETs)
CARCINOID
CONCLUSION AND FUTURE PROSPECTS
INDEX
TOC
Index
×
Chapter Notes
Save
Clear